Furthermore, a steatosis liver, especially in the non-alcoholic steatohepatitis (NASH) stage, releases several proinflammatory cytokines, such as interleukin-1, interleukin-6 and tumor necrosis factors, involved in the activation of deleterious inflammatory pathways. This evidence concerns the gene IL6 and metabolic dysfunction-associated steatohepatitis.